🛡️ What makes an effective QPPV?
August 20, 2026
News
Discover our articles and industry news
EMA publishes PRAC recommendations on safety signals
August 18, 2026
EMA publishes PRAC recommendations on safety signals
The European Medicines Agency (EMA) has published an overview of the recommendations adopted by the…
💊 The Role of a Pharmacovigilance Service Provider: Much More Than Operational Support
August 13, 2026
💊 The Role of a Pharmacovigilance Service Provider: Much More Than Operational Support
Pharmacovigilance is a critical responsibility for every pharmaceutical company. Behind every medicine made available to…
💊 Pharmacovigilance. Expertise you can rely on.
August 11, 2026
💊 Pharmacovigilance. Expertise you can rely on.
Keeping patients safe requires more than compliance — it requires expertise, responsiveness and attention at…
Behind every safety report, there is more than data
July 30, 2026
Behind every safety report, there is more than data
There is expertise that ensures every case is assessed with accuracy. There are robust processes…
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026
July 28, 2026
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 July 2026
The European Medicines Agency (EMA) has published the highlights from the CHMP meeting held on…
⏱️ 24/7: Because patient safety never takes a break.
July 23, 2026
⏱️ 24/7: Because patient safety never takes a break.
Behind every adverse event report lies a critical mission: identifying, assessing, and managing safety information…
EMA releases ICH E6 (R3) Guideline for Good Clinical Practice Step 5
The European Medicines Agency (EMA) has published the consolidated version of ICH E6 (R3) Guideline…
Tailored Pharmacovigilance Services for Your Needs
July 16, 2026
Tailored Pharmacovigilance Services for Your Needs
Every organisation has unique challenges. At Pharmya, we deliver flexible and tailored pharmacovigilance solutions to…
Meeting highlights from the PRAC: 6-9 July 2026
July 15, 2026
Meeting highlights from the PRAC: 6-9 July 2026
The PRAC (Pharmacovigilance Risk Assessment Committee) agreed on Direct Healthcare Professional Communications (DHPCs) for the…
☀️ Summer brings higher temperatures—but pharmacovigilance never takes a holiday
Heat exposure can affect the stability of certain medicinal products, potentially impacting their quality, efficacy,…
EMA publishes PRAC recommendations on safety signals
July 7, 2026
EMA publishes PRAC recommendations on safety signals
The European Medicines Agency (EMA) has published an overview of the recommendations adopted by the…
CTIS sponsor handbook updated
July 2, 2026
CTIS sponsor handbook updated
The European Medicines Agency (EMA) has released version 6.3 of the Clinical Trials Information System…
EMA publishes 2025 AI Observatory report
July 1, 2026
EMA publishes 2025 AI Observatory report
The European Medicines Agency (EMA)’s 2025 AI Observatory report highlights developments in guidance and policy,…
Pharmacovigilance works when collaboration works
June 23, 2026
Pharmacovigilance works when collaboration works
💊 Pharmacovigilance works when collaboration works 🤝 No safety without cooperation. 🌍 Safer medicines are…
The EMA releases Annual Report 2025
June 18, 2026
The EMA releases Annual Report 2025
The European Medicines Agency (EMA) has released its Annual Report 2025, highlighting key initiatives and…
The EMA releases Q&A on the use of real-world data
June 11, 2026
The EMA releases Q&A on the use of real-world data
The European Medicines Agency (EMA) has published a Questions and Answers document aimed at clarifying…
